Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × toripalimab × Clear all

NCT07277322 2026-03-02

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07281716 2026-02-19

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms